Over the past 12 months, 4 insiders at ADMA BIOLOGICS, INC. filed 20 open-market SEC Form 4 transactions on ADMA: 5 purchases worth $468K and 15 sales worth $2.6M. Insiders have been net sellers over this period. The most recent filing was on May 27, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| May 27, 26 | Jerrold B Grossman | BUY | 6.4K | $7.91 | $51K |
| May 12, 26 | Jerrold B Grossman | BUY | 12.5K | $8.01 | $100K |
| May 11, 26 | Jerrold B Grossman | BUY | 12.5K | $8.01 | $100K |
| Mar 16, 26 | Adam S GrossmanPresident and CEO | SELL | 15.0K | $15.16 | $227K |
| Mar 9, 26 | Kaitlin M. Kestenberg-messinaCOO and SVP, Compliance | SELL | 10.1K | $15.63 | $158K |
| Mar 6, 26 | Steve ElmsDirector | BUY | 7.0K | $15.39 | $108K |
| Mar 5, 26 | Steve ElmsDirector | BUY | 7.0K | $15.67 | $110K |
| Feb 17, 26 | Adam S GrossmanPresident and CEO | SELL | 15.0K | $16.08 | $241K |
| Dec 15, 25 | Adam S GrossmanPresident and CEO | SELL | 15.0K | $19.79 | $297K |
| Nov 19, 25 | Adam S GrossmanPresident and CEO | SELL | 15.0K | $16.00 | $240K |
| Oct 24, 25 | Adam S GrossmanPresident and CEO | SELL | 15.0K | $16.00 | $240K |
| Sep 15, 25 | Adam S GrossmanPresident and CEO | SELL | 15.0K | $16.13 | $242K |
| Aug 15, 25 | Adam S GrossmanPresident and CEO | SELL | 15.0K | $16.88 | $253K |
| Jul 15, 25 | Adam S GrossmanPresident and CEO | SELL | 15.0K | $18.66 | $280K |
| Jun 16, 25 | Adam S GrossmanPresident and CEO | SELL | 15.0K | $20.81 | $312K |
| Jun 16, 25 | Steve ElmsDirector | SELL | 194.7K | $20.24 | $3.9M |
| Jun 13, 25 | Steve ElmsDirector | SELL | 137.9K | $20.82 | $2.9M |
| Jun 12, 25 | Steve ElmsDirector | SELL | 92.9K | $21.69 | $2.0M |
| Jun 9, 25 | Jerrold B GrossmanDirector | SELL | 10.0K | $21.31 | $213K |
| Jun 9, 25 | Lawrence P. GuiheenDirector | SELL | 20.0K | $20.96 | $419K |
| May 22, 25 | Lawrence P. GuiheenDirector | SELL | 1.2K | $20.12 | $25K |
| May 21, 25 | Lawrence P. GuiheenDirector | SELL | 7.8K | $20.32 | $158K |
| May 15, 25 | Adam S GrossmanPresident and CEO | SELL | 15.0K | $19.45 | $292K |
| Apr 15, 25 | Adam S GrossmanPresident and CEO | SELL | 15.0K | $21.46 | $322K |
| Mar 19, 25 | Adam S GrossmanPresident and CEO | SELL | 15.0K | $18.92 | $284K |
| Nov 22, 24 | Adam S GrossmanPresident and CEO | SELL | 49.0K | $21.10 | $1.0M |
| Nov 22, 24 | Brad L. TadeCFO and Treasurer | SELL | 15.0K | $21.15 | $317K |
| Sep 9, 24 | Lawrence P. GuiheenDirector | SELL | 9.0K | $18.47 | $166K |
| Aug 30, 24 | Kaitlin M. Kestenberg-messinaCOO and SVP, Compliance | SELL | 24.1K | $16.90 | $408K |
| Aug 29, 24 | Jerrold B GrossmanDirector | SELL | 136.9K | $17.27 | $2.4M |
| Aug 27, 24 | Adam S GrossmanPresident and CEO | SELL | 389.4K | $17.29 | $6.7M |
| Aug 26, 24 | Adam S GrossmanPresident and CEO | SELL | 236.9K | $17.69 | $4.2M |
| Aug 23, 24 | Young KwonDirector | SELL | 60.0K | $18.26 | $1.1M |
| Jun 14, 24 | Adam S GrossmanPresident,CEO, and Interim CFO | SELL | 100.0K | $10.72 | $1.1M |
| Mar 19, 24 | Steve ElmsDirector | SELL | 411.8K | $6.08 | $2.5M |
| Mar 18, 24 | Steve ElmsDirector | SELL | 49.9K | $6.01 | $300K |
| Mar 15, 24 | Steve ElmsDirector | SELL | 183.0K | $6.01 | $1.1M |
| Mar 14, 24 | Steve ElmsDirector | SELL | 448.3K | $6.05 | $2.7M |
| Mar 13, 24 | Steve ElmsDirector | SELL | 407.0K | $6.21 | $2.5M |
| Aug 30, 23 | Jerrold B GrossmanDirector | BUY | 130.0K | $3.71 | $482K |
| Aug 24, 23 | Young KwonDirector | BUY | 25.0K | $3.90 | $98K |
| Aug 22, 23 | Bryant FongDirector | SELL | 1.43M | $3.87 | $5.5M |
| Aug 18, 23 | Adam S GrossmanPresident and CEO | SELL | 250.0K | $4.15 | $1.0M |
| Aug 16, 23 | Adam S GrossmanPresident and CEO | SELL | 3 | $4.39 | $13 |
| Aug 16, 23 | Brian LenzEVP, CFO | SELL | 178.2K | $4.45 | $793K |
| Aug 15, 23 | Adam S GrossmanPresident and CEO | SELL | 510.5K | $4.54 | $2.3M |
| Aug 15, 23 | Brian LenzEVP, CFO | SELL | 211.6K | $4.60 | $973K |
| Dec 9, 22 | Adam S GrossmanPresident and CEO | BUY | 15.0K | $2.86 | $43K |
| Dec 9, 22 | Brian LenzEVP, CFO | BUY | 7.0K | $2.86 | $20K |
| Oct 25, 21 | Adam S GrossmanPresident and CEO | BUY | 250.0K | $1.00 | $250K |
Over the past 12 months, insiders at ADMA BIOLOGICS, INC. filed 5 open-market purchases worth $468K and 15 sales worth $2.6M on ADMA, which makes them net sellers over the period. The most recent Form 4 was filed on May 27, 26.
The largest recent open-market ADMA insider purchase in our data was $482K by Jerrold B Grossman, Director, filed on Aug 30, 23.
4 different insiders at ADMA BIOLOGICS, INC. filed open-market SEC Form 4 transactions on ADMA over the last 12 months.
InsiderTape plots every ADMA insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every ADMA BIOLOGICS, INC. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →